TheStreet.com RealMoney

Too Early to Sell the Soft Goods

By Jim Cramer

 About this article:
 So now we hate the drug stocks. Now we think they aren't delivering on the numbers. We are selling Merck and Schering and we hate Johnson & Johnson . We dismiss the upside surprise for Forest Labs . Celgene's weak again, so hated, so despised despite so many positives. I say this is all business as usual. Every time we think oil has bottomed, we sell these stocks. When we see anything good -- a Freeport that doesn't go down on a downgrade, a Baltic Freight Index rally, anything that shows a pulse for the economy -- we get a selloff in the stocks of businesses that are delivering double digits. I have a problem with this. Take J&J. Here's a company that's taking advantage of the declines in stocks and is buying up higher-growth companies to ensure out-year growth. The market doesn't...

You have just read the beginning of a premium article from our RealMoney Service. To read the rest of this article and sign up for a FREE trial please click below.

ACCESS STORY & START A FREE 14-Day Trial
Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.



Already a RealMoney subscriber? LOG IN.
Username: Page data is submitted securely.
Password:
Forgot your Password? Click here


100% Money-Back Guarantee
If you decide to subscribe and you're not completely satisfied with TheStreet.com RealMoney, just call us within the first 30 days of your subscription and we'll refund your full annual subscription price — guaranteed.




If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.

Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.

If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.

TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.

© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.